FDA Approves First-In-Class Med for Parkinson's Disease
Today's FDA approval of tavapadon makes it the first selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease.
www.medscape.com
FDA Approves First-In-Class Med for Parkinson's Disease
- Thread starter Jaybee00
- Start date